Thus, exploring the potential of the selective inhibition of USP7 and/or PHF8 enzyme activity, particularly in combination with chemotherapy or radiation therapy, may be worthwhile for treatment refinement of breast cancer. Here, PHF8 is linked to breast carcinoma.